-
Quince Therapeutics (NASDAQ:QNCX) Receives "Buy" Rating from D. Boral Capital
Source: Buzz FX / 05 Feb 2025 07:41:10 America/Chicago
Quince Therapeutics (NASDAQ:QNCX) Receives "Buy" Rating from D. Boral Capital Written by MarketBeat February 5, 2025 Share Link copied to clipboard. Quince Therapeutics ( NASDAQ:QNCX - Get Free Report ) 's stock had its "buy" rating reissue
Read more...